Wegovy pill shows 21.6% weightloss in 1/3 of users
Novo Nordisk published data today showing that almost a third of adults taking the Wegovy Pill in a trial responded early to treatment, losing an average 13.2% of their body weight after only four months, before going on to achieve 21.6% weight loss by the end of the 64-week trial.
This data might be interesting for those assessing whether to choose the Wegovy pill, Foundayo or injectables. That Wegovy pill weightloss number beats even injectable Mounjaro/Zepbound.